Rapid Release Ginger Nighttime
Natural health product licensed in Canada
- Other names
- Rapid Release Ginger Nighttime with 3 mg Melatonin per capsule, Rapid Release Ginger Nighttime with Melatonin, Rapid Release Ginger with 3mg of Melatonin, Rapid Release Ginger with Melatonin
- Licence holder
- ProMed Pharmaceutical Inc.
- NPN or DIN-HM
- 80079336
- Status
- Inactive licence
- Licence date
- 4 August 2017
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Gélatine, Eau purifiée, NA, Carbonate de calcium, Sorbitol, Glycérine, Vitamine E, Curcuma, Collagène partiellement hydrolysé
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Traditionally used in Herbal Medicine to help relieve digestive upset/disturbances including lack of appetite, nausea, digestive spasms, indigestion, dyspepsia and flatulent colic (carminative). Help(s) prevent nausea and vomiting associated with motion sickness, and/or seasickness. Helps increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule, e.g., shift-work and jet lag. Helps to prevent and/or reduce the effects of jet lag. Helps to reduce teh time it takes to fall asleep (sleep onset latency aspect of sleep quality) in people with delayed sleep disorder. Helps re-set the body's sleep-wake cycle.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80079336
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.